Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

374.47
+5.311.44%
Post-market: 374.470.00000.00%19:30 EDT
Volume:252.60K
Turnover:95.12M
Market Cap:42.69B
PE:67.00
High:379.48
Open:375.00
Low:374.37
Close:369.16
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:0.59
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:8.25
PE(LYR):151.61

Loading ...

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B

MT Newswires Live
·
Aug 05

BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview

Reuters
·
Aug 03

Is BeOne Medicines (ONC) Stock Priced For Perfection On Earnings?

Simply Wall St.
·
Jul 30

Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan

Stock News
·
Jul 30

BeOne Medicines Targets Esophageal Cancer With New Tislelizumab Trial in Japan

TIPRANKS
·
Jul 30

Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish

Earnings Agent
·
Jul 29

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

Stock News
·
Jul 24

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

Deep News
·
Jul 24

BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing

MT Newswires Live
·
Jul 23

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.
·
Jul 22

Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5

Dow Jones
·
Jul 17

BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes

Simply Wall St.
·
Jul 16

How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story

Simply Wall St.
·
Jul 15

BeOne Medicines (ONC) Gets a Buy from Barclays

TIPRANKS
·
Jul 14

BeOne Medicines Advances Sonrotoclax Formulation Study, Signaling Progress in ONC Pipeline

TIPRANKS
·
Jul 10

BeOne Medicines treatment of pancreatic cancer granted orphan status

TIPRANKS
·
Jul 09

BEIGENE Awards Aggregate 33,400 Restricted Stock Units Represented by American Depositary Shares

Stock News
·
Jul 08

BEIGENE Shares Surge Over 4% on Positive Phase 3 Clinical Trial News for Zanubrutinib

Stock News
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)

TIPRANKS
·
Jul 01